Jordi Rimola

Also affiliated with Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Centre for Genomic Regulation, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice”.

A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice

Nature Reviews Gastroenterology & Hepatology(2024)10.1038/s41575-024-00935-y

N/A

1.4DataRank · unranked

77 citations

Mark E. Baker, Joel G. Fletcher, Vipul Jairath, Cathy Lu, Willem A. Bemelman +24 more

International expert guidance for defining and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound: a consensus statement

The Lancet. Gastroenterology & hepatology(2024)10.1016/s2468-1253(24)00265-6

N/A

0.529DataRank · unranked

33 citations

Ryan E. Rosentreter, Claire E. Parker, Julie Rémillard, Stephanie R. Wilson, Mark E. Baker +21 more

Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease

Radiology(2024)10.1148/radiol.233038

N/A

0.476DataRank · unranked

18 citations

Christopher Ma, Jurij Hanžel, Joel G. Fletcher, Mark E. Baker, Zhongya Wang +15 more

Interim analysis of the ACTION trial: Cabozantinib for hepatocellular carcinoma patients who discontinued first line treatment other than sorafenib or due to sorafenib intolerance

Journal of Hepatology(2023)10.1016/s0168-8278(23)01381-8

N/A

0.104DataRank · unranked

1 citations

Sergio Muñoz Martinez, Mariona Calvo, Maria Varela, Neus Llarch, Gemma Iserte +13 more

Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease

Radiology(2024)10.1148/radiol.233039

N/A

0DataRank · unranked

21 citations

Mark E. Baker, David H. Bruining, Jeff L. Fidler, Eric C. Ehman, Shannon P. Sheedy +24 more

Evidence and choice: The BCLC vision for tailoring clinical decision-making

Journal of Hepatology(2024)10.1016/j.jhep.2024.04.023

N/A

0DataRank · unranked

3 citations

Alejandro Forner, Jordi Rimola, Joana Ferrer, Marta Burrel, Ángeles García‐Criado +11 more

Crohn Disease Strictures: Multimodality Imaging to Identify Imaging Biomarkers

Radiographics(2025)10.1148/rg.240226

N/A

0DataRank · unranked

1 citations

Jonathan R. Dillman, Stuart A. Taylor, Jordi Rimola, Bachir Taouli, Kathryn A. Robinson +11 more

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Journal of Hepatology(2021)10.1016/j.jhep.2021.11.018

N/A

0DataRank · unranked

4206 citations

Alejandro Forner, Jordi Rimola, Joana Ferrer, Marta Burrel, Ángeles García‐Criado +11 more